History

History

History

Establishment through 1960

1947	Company founded
1951	Began producing rutin
1952	Began producing berberine chloride
1955	Began producing dl-methylephedrine hydrochloride (began manufacturing synthetic APIs)
1958	Began producing calcium pantothenate

1961 - 1980

1961	Began producing pyridoxine hydrochloride
1965	Recognized by the Minister of International Trade and Industry as a successful exporter for 7 consecutive years from 1965
1969	Began producing natural pigments
1969	Completed the H-14 Testing Laboratory
1970	Technology licensing to India for production method of berberine chloride
1972	Began production dl-calcium pantothenate
1972	Began producing scopolamine butylbromide
1974	Completed the K-1 Warehouse
1975	Completed the K-2 Factory and started production of pentoxyverine citrate
1977	Completed the K-3 phenylpropanolamine hydrochloride Factory
1979	Completed the rutin facility at H-10
1980	Completed the K-5 β-alanine Factory
	Completed the waste water treatment plant
	Completed the H-22 Factory for extraction of Chinese herbal medicine

1981 - 2000

1983	Introduced frozen pulverization equipment at H-12E
1986	Completed the K-8 Kampo Factory
	Began producing calcium sennoside
	Established a joint venture, Xinjiang Tianshan Pharmaceutical Ind. Co., Ltd., in Urumqi, Xinjiang Uyghur Autonomous Region, China
1987	Completed the K-6 Chinese Herbal Medicine Second Factory
1988	Completed the K-10 Rutin Factory
1988	Established Okamae Warehouse Ltd.
1990	Completed the K-11 Warehouse
1991	Introduced frozen pulverization equipment at K-1 factory
1991	Completed the T-1 Kampo Factory at Toyama Plant
1993	Completed the Welfare Building
1994	Completed the K-12M Multi Purpose Synthesis Factory
1995	Completed the H-7 sub-packaging equipment
1995	Introduced equipment for herbal extraction at H-6 Factory
1996	Established a subsidiary, Qingdao Taitong Pharmaceutical Co., Ltd., in Qingdao, Shandong, China
1997	Completed the K-13M Synthesizing Plant and started production of l-PPA
	Completed new head office building (to accommodate administrative offices and quality control divisions)
	Opened the l-PPA Factory at the Kamino Plant
1998	Received a Community Revitalization Award
	Completed the K-10S Sennoside Factory
	Established a wastewater incineration facility at the Kamino Plant (to comply with dioxin regulations)
1999	The Kamino and Toyama Plants acquired ISO 14001 certification
2000	Completed the TT-2 L-rhamnose Plant in Qingdao Taidong Pharmaceutical Co., Ltd.

2001 -

2001	The Main Plant acquired ISO 14001 certificatio
2001	Completed production facilities for H-17 Health Food Material”
2002	Completed the H-13 Research Building and Herbal Medicine / Synthesis Experiment Factory
2003	Completed the K-13T Factory for highly potent substances
2006	Introduced High-physiological Labotory in the H-13 Research Building
2007	Completed the K-2S Steroid Factory
2008	Expanded the laboratories for highly potent substances
2009	Completed LPG fuel conversion facility at Toyama Plant
2010	Completed LPG fuel conversion facility at Kamino Plant
2011	Started cultivation of ingredients for crude drugs
2012	Fortification of waste water treatment facility
2012	K12S facility expansion for contract manufacturing product
2013	Completed the K-8 Factory for Methylhesperidin and Health Food Materials
	Expanded K-10S Sennoside Factory
	Began pilot cultivation of high content chili peppers in Hida City
	Started cultivation of “high-capacity pepper” in Hida City
2014	Completed the H-20 Berberine Factory
2015	Completed K-13C Second Factory for Highly-bioactive Substance
2016	Began supplying products derived from cultivated licorice
	K13T facility expansion for contract manufacturing product
	Installed new cleaning equipment dedicated for work clothes
2018	Recognized as a local leader of enterprise by the Ministry of Economy, Trade and Industry
	Employed fixed age of retirement at 65
	Pilot cultivation project of sennosides in Myanmar was selected for JICA SDGs business survey
2020	Completed installation of K13M production facilities for Glycyrrhetinic Acid and Stearyl Glycyrrhetinate